Mary Kay Ladone is the Senior Vice President of Corporate Development, Strategy and Investor Relations at Hillrom. Mary has over 20 years of experience in developing and executing corporate and M&A strategies. Prior to their current role, they served as the Corporate Officer and Senior Vice President of Corporate Development, Strategy and Investor Relations at Hill-Rom from July 2016 to January 2022. In this role, they were responsible for leading the global strategic Investor Relations program and the M&A/Corporate Development and Strategy team. Under their leadership, Hillrom more than doubled its market capitalization and achieved 125%+ stock appreciation over 4 years.
In their previous role at Bioventus, Mary Kay Ladone was responsible for leading the company's M&A/business development activities. During their tenure, they closed 8 M&A deals in 24 months and improved the Board's M&A transaction review process by enhancing discipline in evaluating transactions/providing all needed relevant information. Mary also increased the quality of M&A opportunities by increasing the scope of opportunities considered.
Mary Kay Ladone has a BA in Finance / Economics from the University of Notre Dame.
Mary Kay Ladone reports to John P. Groetelaars, President & CEO. Mary Kay Ladone works with Ken Meyers - Senior Vice President, Chief Human Resources Officer, Amy Dodrill - President, Global Surgical Solutions, and Richard Marritt - Senior Vice President, Chief Marketing Officer.
Current role